Cargando…
Testing the treatment effect on competing causes of death in oncology clinical trials
BACKGROUND: Chemotherapy is expected to reduce cancer deaths (CD), while possibly being harmful in terms of non-cancer deaths (NCD) because of toxicity. Peto’s log-rank test is popular in the medical literature, but its operating characteristics are barely known. We compared this test to the most co...
Autores principales: | Rotolo, Federico, Michiels, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047005/ https://www.ncbi.nlm.nih.gov/pubmed/24884550 http://dx.doi.org/10.1186/1471-2288-14-72 |
Ejemplares similares
-
Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology
por: Texier, Matthieu, et al.
Publicado: (2018) -
Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials
por: Ternès, Nils, et al.
Publicado: (2017) -
Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces
por: Ternès, Nils, et al.
Publicado: (2016) -
Prediction of treatment benefit in high-dimensional cox models via gene signatures in randomized clinical trials
por: Ternès, Nils, et al.
Publicado: (2015) -
An alternative trial-level measure for evaluating failure-time surrogate endpoints based on prediction error
por: Belhechmi, Shaima, et al.
Publicado: (2019)